AWS for Industries

Moderna Webinar: Building the Digital Biotech Company

Moderna is advancing messenger RNA (mRNA) science to create a new class of mRNA medicines designed to direct the patient’s own cells to produce proteins that have a therapeutic or preventive benefit. Developing therapeutics and vaccines for a variety of diseases challenges process development and operations to establish agile and flexible manufacturing, capable of executing complex bioprocesses. Optimizing the digital infrastructure of the entire organization- from back office, to small batch manufacturing, to delivery of drug candidates to patients in clinical studies- requires integrated and intelligent systems. Hear from Moderna’s Chief Digital and Operational Excellence Officer how they have used AWS to eliminate data silos, accelerate data-driven decisions at an enterprise level, and established a production environment capable of consistent delivery of complex drug products including a “batch of one”.

In this webinar you will learn:

  • How Moderna uses cloud computing, analytics and data science to accelerate the research, discovery, and clinical development of messenger RNA therapies
  • How Moderna has created a fully digital infrastructure to fully leverage the value of data and facilitate a complex production environment
  • How to optimize digital tools, data, and automation to create a flexible and highly integrated biotech enterprise to drive rapid growth

[Access Webinar]: Building the Digital Biotech Company

Duration: 45 min

Featured Speaker

Marcello Damiani- Chief Digital and Operational Excellence Officer,  Moderna, Inc.

Marcello has 20-years experience working in the IT field, with the last 10 years being spent in leadership roles for multinational companies. Marcello has been instrumental in conceiving and building creative IT solutions to help solve business challenges previously at Motorola and bioMerieux, and now at Moderna. He is known for his ability to transform a company’s information flow, and ultimately improving the product and the company’s processes through digitization. Marcello possesses a Master of Science degree in Information Systems Architecture from the University of Toulouse in France, and an international Executive MBA through TRIUM, an alliance of three of the world’s top universities: the London School of Economics, New York University’s Stern Business School, and the HEC School of Management in Paris.

 

Click here to learn more about AWS for Biotech

Kelli Jonakin, Ph.D.

Kelli Jonakin, Ph.D.

Kelli Jonakin is the Principal Marketing Manager for the Life Sciences and Genomics Industry verticals at AWS. She comes with a background in pharmaceutical research, with a special focus on development and commercialization of biologics. Kelli received her Ph.D. in Pharmacology and Systems Biology from the University of Colorado, and received an NIH post-doctoral fellowship grant to study Biochemistry at the University of Wisconsin-Madison.